News

02.09.2016 - altona Diagnostics' RealStar® Zika Virus RT-PCR Kit 1.0 receives EUA for Korea

altona Diagnostics’ RealStar® Zika Virus RT-PCR Kit 1.0 received Emergency Use Authorization (EUA) from the Korea Centers for Disease Control & Prevention (KCDC).

Read more

19.08.2016 - altona Diagnostics Test for Zika virus accepted by WHO

WHO has accepted the first Zika virus Diagnostic test eligible for procurement agencies and Member States. The RealStar® Zika Virus RT-PCR Kit 1.0 manufactured by altona Diagnostics was assessed under the Emergency Use Assessment and Listing Procedure (EUAL) opened to candidate in vitro diagnostics (IVDs) intended for Zika virus diagnosis in February 2016.

Read more

20.05.2016 - altona Diagnostics Receives Emergency Use Authorization of RealStar® Zika Virus RT-PCR Kit U.S.

The RealStar® Zika Virus RT-PCR Kit U.S. is a real-time RT-PCR test  intended for the qualitative detection of RNA from the Zika virus in serum or urine (collected alongside a patient-matched serum specimen) from individuals meeting CDC Zika virus clinical criteria (e.g., clinical signs and symptoms associated with Zika virus infection) and/or CDC Zika virus epidemiological criteria (e.g., history of residence in or travel to a geographic region with active Zika virus transmission at the time of travel, or other epidemiologic criteria for which Zika virus testing may be indicated), by laboratories in the United States that are certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests, or by similarly qualified non-U.S. laboratories.

Read more

altona Diagnostics GmbH
Mörkenstr. 12
22767 Hamburg
Germany

phone +49 40 548 06 76 - 0
fax +49 40 548 06 76 - 10
e-mail info@altona-diagnostics.com